According to the latest report by IMARC Group, titled “Global Pneumonia Testing Market Report, Size, Share, Industry Trends, Growth, Opportunity and Forecast 2022-2027“, the global pneumonia testing market reached a value of US$ XX Million in 2021. Looking forward, IMARC Group expects the market to grow at a CAGR of XX% during 2022-2027.
Pneumonia is an infection or inflammation that affects the lower respiratory tract caused by microorganisms such as viruses, bacteria, fungi, and parasites. It is characterized by symptoms such as fever, short breathing, chest pain, nausea, and vomiting, which mostly affects individuals with weak immune systems. It is diagnosed through pneumonia testing, which includes a physical examination, medical history review, blood culture, chest X-ray, sputum culture, pulse oximetry, bronchoscopy, and fluid sample.
Pneumonia Testing Market Trends and Drivers:
The market is primarily driven by the rising adoption of point of care (POC) diagnosis to detect pneumonia due to its higher efficiency and accurate test results. In addition, the emergence of immunochromatographic, pneumococcal urinary antigen (UAT) and advanced nucleic acid detection tests represent another major growth-inducing factor.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/pneumonia-testing-market/requestsample
Besides this, governments of numerous countries are making huge investments in developing healthcare infrastructure. This, coupled with the growing awareness among the masses regarding early diagnosis, is escalating the number of pneumonia testing across the globe.
Furthermore, the increasing adoption of enzyme-linked immunosorbent assay (ELISA) to detect pneumonia, the rising geriatric population that is more susceptible to the infection, and the expanding healthcare industry are some of the other factors propelling the market growth.
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Global Pneumonia Testing Market 2022-2027 Analysis and Segmentation:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc, Curetis GmbH (OpGen), DiaSorin S.p.A., Hologic Inc, Meridian Bioscience Inc, Quest Diagnostics Incorporated, Quidel Corporation, Roche Holding AG, and Thermo Fisher Scientific Inc.
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/pneumonia-testing-market
The report has segmented the market on the basis of region, type, method, technology and end user.
Breakup by Type:
Breakup by Method:
- Molecular Diagnostics
- Point of Care Testing
Breakup by Technology:
- Enzyme-linked Immunosorbent Assay
- Western Blot
- Polymerase Chain Reaction
Breakup by End User:
- Diagnostic Laboratories
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Inquire Before Buying : https://www.imarcgroup.com/request?type=report&id=5176&flag=F
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800